Genomictree Inc. (KOSDAQ:228760)
South Korea flag South Korea · Delayed Price · Currency is KRW
17,690
-60 (-0.34%)
Apr 29, 2026, 2:38 PM KST

Genomictree Revenue

In the year 2025, Genomictree had annual revenue of 3.76B KRW with 59.17% growth. Genomictree had revenue of 825.62M in the quarter ending December 31, 2025, with 0.14% growth.

Revenue
3.76B
Revenue Growth
+59.17%
P/S Ratio
115.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
434.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.76B1.40B59.17%
Dec 31, 20242.36B-1.06B-30.89%
Dec 31, 20233.42B-26.45B-88.56%
Dec 31, 202229.87B24.73B481.09%
Dec 31, 20215.14B3.90B314.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SillaJen 9.23B
Helixmith 2.60B
GC Cell 165.52B
Anterogen.Co.,Ltd. 7.54B
BINEX 168.47B
HLB Therapeutics 69.56B
GC Corp. 2,451.48B
Medy-Tox 247.29B
Revenue Rankings